Cargando…

Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464

Detalles Bibliográficos
Autores principales: Mita, Tomoya, Katakami, Naoto, Shiraiwa, Toshihiko, Yoshii, Hidenori, Onuma, Tomio, Kuribayashi, Nobuichi, Osonoi, Takeshi, Kaneto, Hideaki, Kosugi, Keisuke, Umayahara, Yutaka, Yamamoto, Tsunehiko, Matsumoto, Kazunari, Yokoyama, Hiroki, Tsugawa, Mamiko, Gosho, Masahiko, Shimomura, Iichiro, Watada, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439411/
https://www.ncbi.nlm.nih.gov/pubmed/28420697
http://dx.doi.org/10.2337/dc17-er06a
_version_ 1783237945019334656
author Mita, Tomoya
Katakami, Naoto
Shiraiwa, Toshihiko
Yoshii, Hidenori
Onuma, Tomio
Kuribayashi, Nobuichi
Osonoi, Takeshi
Kaneto, Hideaki
Kosugi, Keisuke
Umayahara, Yutaka
Yamamoto, Tsunehiko
Matsumoto, Kazunari
Yokoyama, Hiroki
Tsugawa, Mamiko
Gosho, Masahiko
Shimomura, Iichiro
Watada, Hirotaka
author_facet Mita, Tomoya
Katakami, Naoto
Shiraiwa, Toshihiko
Yoshii, Hidenori
Onuma, Tomio
Kuribayashi, Nobuichi
Osonoi, Takeshi
Kaneto, Hideaki
Kosugi, Keisuke
Umayahara, Yutaka
Yamamoto, Tsunehiko
Matsumoto, Kazunari
Yokoyama, Hiroki
Tsugawa, Mamiko
Gosho, Masahiko
Shimomura, Iichiro
Watada, Hirotaka
author_sort Mita, Tomoya
collection PubMed
description
format Online
Article
Text
id pubmed-5439411
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-54394112018-06-01 Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464 Mita, Tomoya Katakami, Naoto Shiraiwa, Toshihiko Yoshii, Hidenori Onuma, Tomio Kuribayashi, Nobuichi Osonoi, Takeshi Kaneto, Hideaki Kosugi, Keisuke Umayahara, Yutaka Yamamoto, Tsunehiko Matsumoto, Kazunari Yokoyama, Hiroki Tsugawa, Mamiko Gosho, Masahiko Shimomura, Iichiro Watada, Hirotaka Diabetes Care Errata American Diabetes Association 2017-06 2017-04-18 /pmc/articles/PMC5439411/ /pubmed/28420697 http://dx.doi.org/10.2337/dc17-er06a Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle Errata
Mita, Tomoya
Katakami, Naoto
Shiraiwa, Toshihiko
Yoshii, Hidenori
Onuma, Tomio
Kuribayashi, Nobuichi
Osonoi, Takeshi
Kaneto, Hideaki
Kosugi, Keisuke
Umayahara, Yutaka
Yamamoto, Tsunehiko
Matsumoto, Kazunari
Yokoyama, Hiroki
Tsugawa, Mamiko
Gosho, Masahiko
Shimomura, Iichiro
Watada, Hirotaka
Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
title Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
title_full Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
title_fullStr Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
title_full_unstemmed Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
title_short Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
title_sort erratum. sitagliptin attenuates the progression of carotid intima-media thickening in insulin-treated patients with type 2 diabetes: the sitagliptin preventive study of intima-media thickness evaluation (spike). a randomized controlled trial. diabetes care 2016;39:455–464
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439411/
https://www.ncbi.nlm.nih.gov/pubmed/28420697
http://dx.doi.org/10.2337/dc17-er06a
work_keys_str_mv AT mitatomoya erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT katakaminaoto erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT shiraiwatoshihiko erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT yoshiihidenori erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT onumatomio erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT kuribayashinobuichi erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT osonoitakeshi erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT kanetohideaki erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT kosugikeisuke erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT umayaharayutaka erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT yamamototsunehiko erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT matsumotokazunari erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT yokoyamahiroki erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT tsugawamamiko erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT goshomasahiko erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT shimomuraiichiro erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464
AT watadahirotaka erratumsitagliptinattenuatestheprogressionofcarotidintimamediathickeningininsulintreatedpatientswithtype2diabetesthesitagliptinpreventivestudyofintimamediathicknessevaluationspikearandomizedcontrolledtrialdiabetescare201639455464